We thrive on the cutting edge. Staying up to date on new eye treatments allows us to provide the best care options for you.
Our physicians carefully select clinical trials that offer patients new and exciting treatment opportunities.
Study Name: Protocol W
Study Title: Intravitreous Anti-VEGF Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
Study Name: KINGFISHER
Study Title: A 12-Month, 2-Arm, Randomized, Double-Masked, Multicenter Phase III Study Assessing the Efficacy and Safety of brolucizumab every 4 weeks versus Aflibercept every 4 weeks in Adult Patients with Visual Impairment due to Diabetic Macular Edema
Sponsor: Aerie Pharmaceuticals, Inc.
Study Name: Aerie
Study Title: First-in-Human Study of the Safety of AR-13503 Sustained Release Intravitreal Implant in Subjects with Neovascular Age-Related Macular Degeneration (nAMD) and Subjects with Diabetic Macular Edema (DME)
Study Name: MERLIN
Study Title: A multicenter, randomized, double-masked Phase 3a study to assess safety and efficacy of brolucizumab 6 mg q4 weeks compared to aflibercept 2 mg q4 weeks in patients with neovascular age-related macular degeneration (nAMD) with persistent retinal fluid
Sponsor: Chengdu Kanghong Biotechnology
Study Name: PANDA
Study Title: A Multicenter, Double-Masked, Randomized, Dose-Ranging Trial to Evaluate the Efficacy and Safety of conbercept Intravitreal Injection in Subjects with Neovascular Age-related Macular Degeneration
Study Name: OAKS
Study Title: A Phase III, Multi-Center, Randomized, Double-Masked, Sham-Controlled Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy with Same Injections in Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Study Name: Protocol AG
Study Title: Randomized Clinical Trial Assessing the Effects of Pneumatic Vitreolysis on Vitreomacular Traction
Study Name: Protocol AH
Study Title: Single-Arm Study Assessing the Effects of Pneumatic Vitreolysis on Macular Hole